Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 888282 | ISIN: US0010841023 | Ticker-Symbol: AGJ
Tradegate
04.11.24
20:10 Uhr
89,50 Euro
-0,52
-0,58 %
Branche
Fahrzeuge
Aktienmarkt
S&P MidCap 400
1-Jahres-Chart
AGCO CORPORATION Chart 1 Jahr
5-Tage-Chart
AGCO CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
89,3090,8607:41
89,3090,8607:35
PR Newswire
97 Leser
Artikel bewerten:
(0)

American Industrial Partners Completes Acquisition Of Agco's Grain & Protein Business

Rebranded Grain & Protein Technologies, the new standalone entity will be led by accomplished industrial manufacturing leader Jacob Thomas

NEW YORK and DULUTH, Ga., Nov. 1, 2024 /PRNewswire/ -- American Industrial Partners ("AIP"), an industrials investor, today announced the completion of its acquisition of AGCO Corporation's (NYSE: AGCO) Grain & Protein division, which produces grain storage and seed processing solutions as well as feeding, watering, climate management and control systems for worldwide protein production, principally poultry, swine, and egg. In conjunction with the transaction close, it was announced that the new standalone, privately held business will now operate under the name Grain & Protein Technologies ("the Company") with Jacob Thomas serving as CEO.

Serving customers in over 100 countries worldwide, Grain & Protein Technologies employs more than 3,200 people across its 14 manufacturing facilities in North America, Brazil, Europe, and Malaysia, generating an annual revenue of approximately $1 billion. The Company will continue to operate its strong portfolio of brands - GSI, Cumberland, AP, Tecno and Cimbria - which are industry leaders in equipment for grain, seed, poultry, egg, and swine production.

Jacob Thomas joins Grain & Protein Technologies from The Carlstar Group ("Carlstar"), the leading supplier of specialty tires and wheels, where he served as CEO and member of the company's board. During his tenure at Carlstar, a former AIP portfolio company, Thomas successfully led the organization's transformation and sale. Prior to Carlstar, Thomas served in executive leadership positions at Clarcor, IDEX Corporation and the Terex Corporation.

"I am delighted to be partnering with AIP again, and whole-heartedly believe in the potential for value creation of this great group of businesses that have an important purpose of Feeding the World Better," said Jacob Thomas, CEO of Grain & Protein Technologies. "I have been immersed across the enterprise over the last twelve weeks, and I am impressed with the level of talent and commitment. We will emphasize advancing smart technologies and offering innovative technical solutions to our customers to make them more productive and profitable in a sustainable way."

Eric Baroyan, Partner at AIP, added, "Grain & Protein Technologies is a critically important business to the future of the global food supply. With decades of industrial manufacturing expertise and a track record of success building large-scale, global operations, Jacob is the right leader for the Company to ensure it fully capitalizes on its unique market position as the go-to partner for large-scale agriculture worldwide."

Sidley Austin LLP served as legal counsel to AIP. Morgan Stanley & Co. LLC and Rabo Securities USA, Inc. served as financial advisors to AGCO. Santander US Capital Markets LLC served as financial advisor to AIP and its affiliate led the fully committed debt financing. Simpson Thacher & Bartlett LLP served as legal advisor to AGCO.

About American Industrial Partners

American Industrial Partners ("AIP") is an industrials investor, with approximately $16 billion in assets under management. AIP is distinctively focused on industrial businesses across a broad range of end markets that include: aerospace and defense, automotive, building products, capital goods, chemicals, industrial services, industrial technology, logistics, metals & mining, and transportation, among others. AIP looks to generate differentiated returns by investing in quality industrial businesses with strong management teams and working with those teams to implement comprehensive operating agendas to build long-term value. Current AIP portfolio companies generate aggregate annual revenues of approximately $25 billion and employ approximately 65,000 employees as of June 30, 2024. www.americanindustrial.com

About AGCO

AGCO (NYSE: AGCO) is a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology. AGCO delivers value to farmers and OEM customers through its differentiated brand portfolio including core brands like Fendt®, GSI®, Massey Ferguson®, PTx and Valtra®. AGCO's full line of equipment, smart farming solutions and services helps farmers sustainably feed our world. Founded in 1990 and headquartered in?Duluth, Georgia, USA, AGCO had net sales of approximately?$14.4 billion?in 2023. For more information, visit?www.agcocorp.com. For company news, information, and events, please follow us on X: @AGCOCorp. For financial news on X, please follow the hashtag AGCOIR.

Contacts:

Media Inquiries: American Industrial Partners - [email protected]

Media inquiries: AGCO - Rachel Potts, V.P., Chief Communications Officer; 678-654-7719; [email protected]

Investor inquiries: AGCO - Greg Peterson, V.P. Investor Relations; 770-232-8229; [email protected]

SOURCE American Industrial Partners

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.